Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study
Sponsor: Aarhus University Hospital Skejby
Summary
Coronary artery disease is often treated by implantation of permanent metallic stents.Coronary stents are required in the early healing phase after balloon dilatation but constitute a lifelong foreign body. New bioresorbable stents have been developed and are believed to improve long-term safety. The purpose of this study is to compare the safety and vessel healing after treatment of simple bifurcation lesions with the CE-marked bioresorbable stents Absorb and Desolve.
Official title: Bioresorbable Vascular Stents for Treatment of Coronary Bifurcation Lesions Assessed by Optical Coherence Tomography - The BIFSORB Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2016-01
Completion Date
2028-09
Last Updated
2026-01-02
Healthy Volunteers
No
Conditions
Interventions
Absorb
Randomization to implantation of Absorb BVS in bifurcation lesion
Desolve
Randomization to implantation of Desolve BRS in bifurcation lesion
Locations (4)
Aarhus University Hospital
Aarhus N, Denmark
Odense University Hospital
Odense, Denmark
Zealand University Hospital, Roskilde
Roskilde, Denmark
Latvian Heart Center
Riga, Latvia